{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T20:09:20Z","timestamp":1774642160100,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11239-019-01997-5","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T05:42:31Z","timestamp":1574314951000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The dawn of aspirin free strategy after short term dual antiplatelet for percutaneous coronary intervention: meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"49","author":[{"given":"Mohammed","family":"Osman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Farjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khansa","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qais","family":"Radaideh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Bilal","family":"Munir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babikir","family":"Kheiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudarshan","family":"Balla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"1997_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","volume":"68","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA et al (2016) 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 68:1082\u20131115","journal-title":"J Am Coll Cardiol"},{"key":"1997_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41569-018-0049-1","volume":"15","author":"D Capodanno","year":"2018","unstructured":"Capodanno D, Mehran R, Valgimigli M et al (2018) Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention. Nat Rev Cardiol 15:480\u2013496","journal-title":"Nat Rev Cardiol"},{"key":"1997_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1056\/NEJM198308183090703","volume":"309","author":"HD Lewis Jr","year":"1983","unstructured":"Lewis HD Jr, Davis JW, Archibald DG et al (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 309:396\u2013403","journal-title":"N Engl J Med"},{"key":"1997_CR4","first-page":"349","volume":"2","author":"Randomised trial of intravenous streptokinase","year":"1988","unstructured":"Randomised trial of intravenous streptokinase (1988) oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 2:349\u2013360","journal-title":"Lancet"},{"key":"1997_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","volume":"364","author":"HC Diener","year":"2004","unstructured":"Diener HC, Bogousslavsky J, Brass LM et al (2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364:331\u2013337","journal-title":"Lancet"},{"key":"1997_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1","journal-title":"Syst Rev"},{"key":"1997_CR7","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1093\/eurheartj\/ehx597","volume":"39","author":"SU Khan","year":"2018","unstructured":"Khan SU, Duran CA, Rahman H, Lekkala M, Saleem MA, Kaluski E (2018) A meta-analysis of continuous positive airway pressure therapy in prevention of cardiovascular events in patients with obstructive sleep apnoea. Eur Heart J 39:2291\u20132297","journal-title":"Eur Heart J"},{"key":"1997_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR et al (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494\u2013502","journal-title":"N Engl J Med"},{"key":"1997_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1160\/TH11-03-0202","volume":"107","author":"N Mallouk","year":"2012","unstructured":"Mallouk N, Labruyere C, Reny JL et al (2012) Prevalence of poor biological response to clopidogrel: a systematic review. Thromb Haemost 107:494\u2013506","journal-title":"Thromb Haemost"},{"key":"1997_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11239-010-0457-5","volume":"30","author":"G Campo","year":"2010","unstructured":"Campo G, Fileti L, Valgimigli M et al (2010) Poor response to clopidogrel: current and future options for its management. J Thromb Thrombolysis 30:319\u2013331","journal-title":"J Thromb Thrombolysis"},{"key":"1997_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057","journal-title":"N Engl J Med"},{"key":"1997_CR12","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"1997_CR13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","volume":"392","author":"P Vranckx","year":"2018","unstructured":"Vranckx P, Valgimigli M, Juni P et al (2018) Ticagrelor plus aspirin for 1\u00a0month, followed by ticagrelor monotherapy for 23\u00a0months vs aspirin plus clopidogrel or ticagrelor for 12\u00a0months, followed by aspirin monotherapy for 12\u00a0months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet 392:940\u2013949","journal-title":"Lancet"},{"key":"1997_CR14","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1001\/jama.2019.8146","volume":"321","author":"JY Hahn","year":"2019","unstructured":"Hahn JY, Song YB, Oh JH et al (2019) Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE Randomized Clinical Trial. JAMA 321:2428\u20132437","journal-title":"JAMA"},{"key":"1997_CR15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908419","author":"R Mehran","year":"2019","unstructured":"Mehran R, Baber U, Sharma SK et al (2019) Ticagrelor with or without aspirin in high-risk patients after PCI. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1908419","journal-title":"N Engl J Med"},{"key":"1997_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ahj.2019.02.015","volume":"212","author":"C Kim","year":"2019","unstructured":"Kim C, Hong SJ, Shin DH et al (2019) Randomized evaluation of ticagrelor monotherapy after 3-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with new-generation sirolimus-eluting stents: tICO trial rationale and design. Am Heart J 212:45\u201352","journal-title":"Am Heart J"},{"key":"1997_CR17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1056\/NEJMoa1908973","volume":"381","author":"S Schupke","year":"2019","unstructured":"Schupke S, Neumann FJ, Menichelli M et al (2019) Ticagrelor or prasugrel in patients with acute coronary syndromes. N Engl J Med 381:1254\u20131534","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01997-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01997-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01997-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T03:06:11Z","timestamp":1605841571000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01997-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1997"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01997-5","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"21 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}